DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020803
» See Plans and Pricing
NDA 020803 describes ALREX, which is a drug marketed by Bausch And Lomb and is included in one NDA. Additional details are available on the ALREX profile page.
The generic ingredient in ALREX is loteprednol etabonate. There are ten drug master file entries for this compound. Additional details are available on the loteprednol etabonate profile page.
The generic ingredient in ALREX is loteprednol etabonate. There are ten drug master file entries for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 020803
| Tradename: | ALREX |
| Applicant: | Bausch And Lomb |
| Ingredient: | loteprednol etabonate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020803
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.2% | ||||
| Approval Date: | Mar 9, 1998 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 020803
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | Start Trial | Start Trial |
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | Start Trial | Start Trial |
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
